Mots-C
Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1, Mitochondrial-derived peptide MOTS-c
The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury.
Tang. Mi M; Su. Quansheng Q; Duan. Yimei Y; Fu. Yu Y; Liang. Min M; Pan. Yanrong Y; Yuan. Jinghan J; Wang. Manda M; Pang. Xiaoli X; Ma. Jiacheng J; Laher. Ismail I; Li. Shunchang S
Key Findings
- MOTS‑c daily injections reduced heart tissue damage and improved cardiac performance in a type‑2 diabetes rat model.
- MOTS‑c increased antioxidant enzymes (SOD, CAT) and activated the Nrf2‑Keap1 and AMPK pathways, mirroring exercise‑induced protective effects.
- Combining MOTS‑c with aerobic exercise gave the greatest reduction in lipid peroxidation (MDA) and the highest activation of p‑AMPK compared to either treatment alone.
Practical Outcomes
- For biohackers interested in heart health and metabolic resilience, MOTS‑c shows promise as an exercise‑mimetic supplement that could support antioxidant defenses, especially when exercise is limited. However, the data are from rats and use intraperitoneal dosing, so human dosing, safety, and delivery methods remain unknown. Until human trials are available, cautious experimentation (e.g., low‑dose subcutaneous or oral formulations under medical supervision) might be considered, but the primary actionable advice remains to maintain regular aerobic activity.
Summary
In diabetic rats, giving the tiny protein MOTS‑c (0.5 mg per kg body weight each day) helped protect the heart, reduced damage, and improved its function. The benefits were similar to those seen with regular treadmill exercise and were even stronger when MOTS‑c was combined with exercise. The peptide boosted the heart’s natural antioxidant systems (SOD, CAT, Nrf2, p‑AMPK) and lowered harmful oxidative markers.
Abstract
Myocardial remodeling and dysfunction are commonly observed in type 2 diabetes mellitus (T2DM). Aerobic exercise can partly alleviate diabetes-induced myocardial dysfunction through its antioxidant actions. MOTS-c is a potential exercise mimic. This study aimed to investigate the effects of MOTS-c on improving diabetic heart function and its mechanism and to identify whether MOTS-c improved antioxidant defenses due to aerobic exercise. Herein, we established a rat model of T2DM induced by high-fat diet combined with a low-dose streptozotocin injection. Interventions were performed using intraperitoneal injections of MOTS-c (i.p. 0.5 mg/kg/day, 7 days/week) or aerobic exercise training (treadmill, 20 m/min, 60 min/day, 5 days/week) for 8 weeks. Myocardial ultrastructure was assessed using transmission electron microscopy (TEM), myocardial lipid peroxidation levels (MDA), superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) levels were assessed using colorimetric methods, and molecular analyses including MOTS-c, Kelch-like ECH-associated protein 1 (Keap1), Nuclear factor E2-related factor 2 (Nrf2), adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)and phospho-AMPK (p-AMPK) were examined using Western blot. The results showed that MOTS-c, with or without exercise, reduced myocardial ultrastructural damage and improved glucolipid metabolism and cardiac function in T2DM. Furthermore, MOTS-c increased antioxidant markers such as SOD, CAT, and the protein expression of myocardial MOTS-c, Keap1, Nrf2, and p-AMPK. MOTS-c with exercise treatment reduced myocardial MDA and increased p-AMPK significantly comparing to only exercise or MOTS-c alone. Our findings suggest that MOTS-c may be a helpful supplement for overcoming exercise insufficiency and improving myocardial structure and function in diabetes.
Study Information
pubmed
2023
2023-11-13T00:00:00.000Z
10.1038/s41598-023-47073-0
16
47